JP5577889B2 - Skin cosmetics - Google Patents

Skin cosmetics Download PDF

Info

Publication number
JP5577889B2
JP5577889B2 JP2010147875A JP2010147875A JP5577889B2 JP 5577889 B2 JP5577889 B2 JP 5577889B2 JP 2010147875 A JP2010147875 A JP 2010147875A JP 2010147875 A JP2010147875 A JP 2010147875A JP 5577889 B2 JP5577889 B2 JP 5577889B2
Authority
JP
Japan
Prior art keywords
skin
effect
mass
cosmetic
flexibility
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2010147875A
Other languages
Japanese (ja)
Other versions
JP2012012311A (en
Inventor
猛 田村
実咲 石田
和晃 脇田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NOF Corp
Original Assignee
NOF Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NOF Corp filed Critical NOF Corp
Priority to JP2010147875A priority Critical patent/JP5577889B2/en
Publication of JP2012012311A publication Critical patent/JP2012012311A/en
Application granted granted Critical
Publication of JP5577889B2 publication Critical patent/JP5577889B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Cosmetics (AREA)

Description

本発明は皮膚化粧料に関する。さらに詳しくは、肌へ素早くなじむとともに、べたつき感を感じることがなく、保湿効果の持続性、肌の柔軟性改善効果、肌荒れ改善効果および肌保護効果に優れる皮膚化粧料に関する。   The present invention relates to a skin cosmetic. More specifically, the present invention relates to a skin cosmetic that quickly adapts to the skin, does not feel sticky, and has excellent moisture retention effect, skin flexibility improvement effect, skin roughness improvement effect, and skin protection effect.

皮膚の水分を適切な範囲に保つことは、皮膚の健康面において非常に大切なことである。皮膚に元来備わっている天然保湿因子(NMF)は、角層の水分保持に重要な役割を演じている。NMFの量が減少すると、角層の水分保持力の低下、皮膚の乾燥、きめの乱れ、肌荒れなどが起こる。みずみずしく潤いのある肌を保つために、NMFの主成分であるアミノ酸およびその誘導体を、化粧料基剤として用いるための研究が多く行われている。中でも、アルギニン、リジン、ヒスチジン等の塩基性アミノ酸には、生体組織の修復、免疫機能の維持、創傷治癒効果、活性酸素除去作用等があることが知られており、乾燥肌や荒れ肌に適した保湿剤として化粧料に用いられている。しかし、皮膚とのなじみが悪かったり、効果が十分に得られなかったりする場合があり、これらの課題を解決するためにアミノ酸誘導体が検討されている。   Keeping skin moisture within an appropriate range is very important for skin health. Natural moisturizing factor (NMF) inherent in the skin plays an important role in moisture retention in the stratum corneum. When the amount of NMF decreases, the water retention capacity of the stratum corneum is reduced, the skin is dried, the texture is disturbed, and the skin becomes rough. In order to maintain a fresh and moist skin, many studies have been conducted to use amino acids and their derivatives, which are the main components of NMF, as cosmetic bases. Among them, basic amino acids such as arginine, lysine and histidine are known to have biological tissue repair, immune function maintenance, wound healing effect, active oxygen removal action, etc., and are suitable for dry and rough skin It is used in cosmetics as a moisturizing agent. However, there are cases where the familiarity with the skin is poor or the effect is not sufficiently obtained, and amino acid derivatives have been studied in order to solve these problems.

例えば、特許文献1には、N−アセチル塩基性アミノ酸および/またはその塩を含有することを特徴とする化粧料が開示されている。しかしながら、保湿効果の持続性や肌の柔軟性改善効果、肌荒れ改善効果が十分に満足のいくものでなかった。
また、特許文献2には、アミノ酸またはイミノ酸にグリシドールを反応させたアミノ酸のN−グリセリル誘導体またはその酸付加塩を含有することを特徴とする皮膚外用剤が開示されている。しかしながら、肌へのなじみ性やべたつき感、肌保護効果が十分に満足のいくものでなかった。このように、肌へのなじみ性やべたつき感のなさといった肌への感触が良好であり、かつ保湿効果の持続性や肌荒れ防止効果といった肌への改善効果に優れた化粧料はこれまで得られていなかった。
For example, Patent Document 1 discloses a cosmetic comprising N-acetyl basic amino acid and / or a salt thereof. However, the sustainability of the moisturizing effect, the effect of improving skin flexibility, and the effect of improving rough skin were not fully satisfactory.
Patent Document 2 discloses an external preparation for skin containing an N-glyceryl derivative of an amino acid obtained by reacting an amino acid or imino acid with glycidol or an acid addition salt thereof. However, the familiarity with the skin, the feeling of stickiness, and the skin protecting effect were not fully satisfactory. In this way, cosmetics that have good skin feel such as familiarity to the skin and lack of stickiness, as well as excellent skin improvement effects such as a long-lasting moisturizing effect and a rough skin prevention effect, have been obtained so far. It wasn't.

特開2002−87928号公報JP 2002-87928 A 特開2004−83453号公報JP 2004-83453 A

本発明の目的は、肌へ素早くなじむとともに、べたつき感を感じることがなく、保湿効果の持続性、肌の柔軟性改善効果、肌荒れ改善効果および肌保護効果に優れる皮膚化粧料を提供することにある。   An object of the present invention is to provide a skin cosmetic that quickly adapts to the skin, does not feel sticky, and has an excellent moisturizing effect, an improved skin flexibility, an improved rough skin effect, and an excellent skin protective effect. is there.

上記課題を解決するために研究を重ねたところ、式(I)で示されたアルギニン誘導体および水溶性高分子化合物を特定の比率で組み合わせることにより、上記目的を達成できることを見出し、本発明を完成させるに至った。
すなわち、本発明の皮膚化粧料は、(a)式(I)で示されるアルギニン誘導体0.05〜10質量%、(b)水溶性高分子化合物0.01〜3質量%含有する皮膚化粧料であることを特徴とする。
As a result of repeated studies to solve the above problems, it was found that the above object can be achieved by combining the arginine derivative represented by the formula (I) and the water-soluble polymer compound at a specific ratio, and the present invention was completed I came to let you.
That is, the skin cosmetic of the present invention comprises (a) 0.05 to 10% by mass of an arginine derivative represented by the formula (I) and (b) 0.01 to 3% by mass of a water-soluble polymer compound. It is characterized by being.

(R、Rは水素原子又はヒドロキシプロピル基であり、R、Rの少なくともどちらかはヒドロキシプロピル基を示す。Rは水素原子又はアルカリ金属原子を示す。) (R 1 and R 2 are a hydrogen atom or a hydroxypropyl group, and at least one of R 1 and R 2 represents a hydroxypropyl group. R 3 represents a hydrogen atom or an alkali metal atom.)

また、本発明の皮膚化粧料は、さらに、(c)抗炎症剤0.001〜2質量%含有する皮膚化粧料であることを特徴とする。   Moreover, the skin cosmetic of the present invention is further characterized by being (c) a skin cosmetic containing 0.001 to 2% by mass of an anti-inflammatory agent.

本発明の化粧料は、肌へ素早くなじむとともに、べたつき感を感じることがなく、保湿効果の持続性、肌の柔軟性改善効果、肌荒れ改善効果および肌保護効果に優れる。   The cosmetic of the present invention quickly adapts to the skin, does not feel sticky, and is excellent in the durability of the moisturizing effect, the skin flexibility improving effect, the skin roughness improving effect, and the skin protecting effect.

本発明に用いられる(a)成分は式(I)で示され、式(I)中のR、Rは水素原子又はヒドロキシプロピル基であり、少なくともいずれかがヒドロキシプロピル基である。また、式(I)において、Rは水素原子又はアルカリ金属原子であり、アルカリ金属原子としては、例えば、ナトリウム、カリウム、リチウム等が挙げられる。 The component (a) used in the present invention is represented by the formula (I), and R 1 and R 2 in the formula (I) are a hydrogen atom or a hydroxypropyl group, and at least one of them is a hydroxypropyl group. In the formula (I), R 3 is a hydrogen atom or an alkali metal atom, and examples of the alkali metal atom include sodium, potassium, lithium and the like.

本発明の上記式(I)で表されるアルギニン誘導体は、アルギニンとプロピレンオキシドとを水溶媒中、無触媒で反応させることにより得ることができる。具体的には、所定濃度のアルギニン水溶液を調製し、加温しながら、撹拌下、プロピレンオキシドを滴下しながら反応を行うことで、式(I)で表されるアルギニン誘導体が得られる。但し、Rがアルカリ金属である場合、アルギニンとプロピレンオキシドとの反応の後、水酸化ナトリウムといったアルカリ剤と反応させることにより、式(I)で表されるアルギニン誘導体を得ることができる。また、本発明では有機酸や無機酸でアルギニン誘導体の酸付加塩としてもよい。 The arginine derivative represented by the above formula (I) of the present invention can be obtained by reacting arginine and propylene oxide in an aqueous solvent without a catalyst. Specifically, an arginine derivative represented by the formula (I) is obtained by preparing an aqueous arginine solution having a predetermined concentration and performing the reaction while adding propylene oxide while stirring with stirring. However, when R 3 is an alkali metal, an arginine derivative represented by the formula (I) can be obtained by reacting with arginine and propylene oxide followed by an alkali agent such as sodium hydroxide. Moreover, in this invention, it is good also as an acid addition salt of an arginine derivative with an organic acid or an inorganic acid.

(a)成分の配合量は、組成物全量中に0.05〜10質量%、好ましくは0.05〜8質量%、さらに好ましくは0.1〜6質量%である。0.05質量%未満であると、べたつきを生じさせたり、肌へのなじみ性、肌の柔軟性改善効果や肌荒れ改善効果が得られなかったりする場合がある。一方、10重量%を超えると、添加量に見合った効果が得られずコスト面で不利である。   (A) The compounding quantity of a component is 0.05-10 mass% in the composition whole quantity, Preferably it is 0.05-8 mass%, More preferably, it is 0.1-6 mass%. If it is less than 0.05% by mass, stickiness may be caused, or the conformability to the skin, the skin flexibility improvement effect and the skin roughness improvement effect may not be obtained. On the other hand, if it exceeds 10% by weight, an effect commensurate with the amount added cannot be obtained, which is disadvantageous in terms of cost.

本発明に用いられる(b)成分の水溶性高分子化合物は水に溶解したときに多くの水を包含したヒドロゲルを形成し、水溶液の粘度を著しく増大させることのできる性質を有するものであり、界面に吸着して保護コロイド作用、ゲル化作用、乳化作用などの界面活性剤と同様の性質を有するものである。このような性質を有する水溶性高分子としては、植物、微生物、動物などに由来する天然高分子化合物(多糖類、たんぱく質など)、半合成高分子化合物(セルロース系、デンプン系、アルギン酸系など)および合成高分子化合物(ビニル系など)、さらには無機高分子(ベントナイトなど)が挙げられる。具体的には、天然高分子化合物としては、アラビアガム、グアーガム、クインスシードガム、マルメロ、寒天、キサンタンガム、フルクタン、プルラン、ヒアルロン酸ナトリウム、コンドロイチン硫酸ナトリウムなどの多糖類や、ゼラチン、カゼインなどのたんぱく質が挙げられる。半合成高分子化合物としては、カルボキシメチルセルロース、ヒドロキシエチルセルロースなどのセルロース系、可溶性デンプン、カルボキシメチルデンプンなどのデンプン系、アルギン酸ナトリウム、アルギン酸プロピレングリコールなどのアルギン酸系の高分子化合物が挙げられる。合成高分子化合物としては、ポリビニルアルコール、ポリアクリル酸ナトリウム、カルボキシビニルポリマーおよびその変性物、メタクリロイルオキシエチルホスホリルコリン重合物および共重合可能なモノマーとの共重合物などのビニル系、ポリエチレングリコールなどのポリエーテル系の高分子化合物が挙げられる。また、これらの高分子化合物は、電気的性質により陰イオン性、陽イオン性、両性および非イオン性に分けられる。これらの中でも、肌のべたつき感のなさ、肌の柔軟性改善効果、肌荒れ改善効果および肌保護効果から、陰イオン性または両性の高分子化合物が好ましい。具体的には、キサンタンガム、ヒアルロン酸ナトリウム、コンドロイチン硫酸ナトリウム、ポリアクリル酸ナトリウム、カルボキシビニルポリマー、アルキル変性カルキシビニルポリマー、ポリメタクリロイルオキシエチルホスホリルコリン、メタクリロイルオキシエチルホスホリルコリンとメタクリル酸アルキルとの共重合物が好ましく、キサンタンガム、ヒアルロン酸ナトリウム、カルボキシビニルポリマー、メタクリロイルオキシエチルホスホリルコリンとメタクリル酸アルキルとの共重合物が特に好ましい。   The water-soluble polymer compound (b) used in the present invention forms a hydrogel containing a large amount of water when dissolved in water, and has the property of significantly increasing the viscosity of the aqueous solution. It has the same properties as surfactants such as protective colloid action, gelling action, emulsifying action, etc. adsorbed on the interface. Examples of water-soluble polymers having such properties include natural polymer compounds derived from plants, microorganisms, animals, etc. (polysaccharides, proteins, etc.), semi-synthetic polymer compounds (cellulose-based, starch-based, alginic acid-based, etc.). And synthetic polymer compounds (such as vinyl), and inorganic polymers (such as bentonite). Specifically, natural polymer compounds include gum arabic, guar gum, quince seed gum, quince, agar, xanthan gum, fructan, pullulan, sodium hyaluronate, sodium chondroitin sulfate, and proteins such as gelatin and casein. Is mentioned. Examples of the semi-synthetic polymer compound include cellulose compounds such as carboxymethyl cellulose and hydroxyethyl cellulose, starch compounds such as soluble starch and carboxymethyl starch, and alginic acid polymer compounds such as sodium alginate and propylene glycol alginate. Synthetic polymer compounds include polyvinyl alcohol, sodium polyacrylate, carboxyvinyl polymer and modified products thereof, methacryloyloxyethyl phosphorylcholine polymer and copolymers with copolymerizable monomers, such as vinyl-based polymers such as polyethylene glycol, and the like. Examples include ether-based polymer compounds. These polymer compounds are classified into anionic, cationic, amphoteric and nonionic depending on the electrical properties. Among these, anionic or amphoteric polymer compounds are preferable from the viewpoint of lack of skin stickiness, skin flexibility improvement effect, skin roughness improvement effect, and skin protection effect. Specifically, xanthan gum, sodium hyaluronate, sodium chondroitin sulfate, sodium polyacrylate, carboxyvinyl polymer, alkyl-modified carboxyl vinyl polymer, polymethacryloyloxyethyl phosphorylcholine, copolymer of methacryloyloxyethyl phosphorylcholine and alkyl methacrylate Xanthan gum, sodium hyaluronate, carboxyvinyl polymer, and a copolymer of methacryloyloxyethyl phosphorylcholine and alkyl methacrylate are particularly preferable.

(b)成分の配合量は、組成物全量中に0.01〜3質量%、好ましくは0.02〜2.5質量%、さらに好ましくは0.05〜2質量%である。0.01質量%未満の場合は、肌へのなじみ性が悪くなり、保湿効果の持続性、肌の柔軟性改善効果、肌荒れ改善効果および肌保護効果が弱くなる。3質量%を超える場合は、配合が困難になったり、べたつきを生じさせたりする場合があり、さらにコスト面でも不利である。(b)成分は1種単独で用いてもよいし、2種類以上を併用してもよい。   (B) The compounding quantity of a component is 0.01-3 mass% in a composition whole quantity, Preferably it is 0.02-2.5 mass%, More preferably, it is 0.05-2 mass%. When the amount is less than 0.01% by mass, the conformability to the skin is deteriorated, and the durability of the moisturizing effect, the skin flexibility improving effect, the rough skin improving effect and the skin protecting effect are weakened. If it exceeds 3% by mass, blending may become difficult or stickiness may occur, which is also disadvantageous in terms of cost. (B) A component may be used individually by 1 type and may use 2 or more types together.

本発明の皮膚化粧料は、肌の柔軟性改善効果および肌荒れ改善効果をより向上させるために、さらに(c)成分の抗炎症剤を含有することができる。(c)成分の抗炎症剤は、発赤・腫脹などの炎症を抑制し、炎症に伴う組織損壊を軽減する目的で使用する薬剤である。このような作用を有する化合物としては、ステロイド系と非ステロイド系の化合物が挙げられる。ステロイド系抗炎症剤は、間接的にホスホリパーゼA2を阻害し、その結果プロスタグランジンとロイコトリエンの合成が 抑制されることによって抗炎症作用をもたらす。一方、非ステロイド系抗炎症剤は、プロスタグランジンの合成酵素であるシクロオキシゲナーゼ(COX)の働きを阻害し、発痛物質(痛みを誘発する物質)を抑制して抗炎症作用や鎮痛作用、解熱作用、抗血栓作用をもたらす。具体的には、ステロイド系抗炎症剤としてプレドニゾロン、ベクロメタゾン、ベタメタゾン、フルチカゾン、デキサメタゾン、ヒドロコルチゾンなどの他、ステロイドサポニンや麦門冬エキスなどのステロイドサポニンを含有する植物エキスがある。また、非ステロイド系抗炎症剤としてアラントイン、グアイアズレン、インドメタシン、ケトプロフェン、ピロキシカム、アセトアミノフェン、アスピリン、サリチル酸、ブフェマキサク、スプロフェン、イブプロフェンピコノール、フルルビプロフェン、プラノプロフェン、ジクロフェナクナトリウム、サリチル酸ナトリウム、サリチル酸メチル、ベンザダック、フェルビナク、ウフェルナマート、塩酸ジフェンヒドラミンなどの他に、グリチルリチン酸やグリチルレチン酸およびそれらの塩やエステル化物であるトリテルペノイドサポニンや甘草エキスなどのトリテルペノイドサポニンを含有する植物エキス、プロポリスエキスがある。これらの中で、継続使用による安全性を考慮すると非ステロイド系抗炎症剤が好ましく、また、肌の柔軟性改善効果および使用感の向上を考慮すると、グリチルリチン酸およびその塩、グリチルレチン酸およびその塩またはエステル化物、アラントイン、グアイアズレンがより好ましく、グリチルリチン酸塩がさらに好ましい。   The skin cosmetic of the present invention can further contain an anti-inflammatory agent as component (c) in order to further improve the skin softness improving effect and the rough skin improving effect. The anti-inflammatory agent (c) is a drug used for the purpose of suppressing inflammation such as redness and swelling and reducing tissue damage associated with inflammation. Examples of the compound having such an action include steroidal and non-steroidal compounds. Steroidal anti-inflammatory agents indirectly inhibit phospholipase A2, resulting in an anti-inflammatory effect by suppressing the synthesis of prostaglandins and leukotrienes. On the other hand, non-steroidal anti-inflammatory drugs inhibit the action of cyclosoxygenase (COX), a prostaglandin synthase, and suppress pain-inducing substances (substances that induce pain), thereby providing anti-inflammatory, analgesic and antipyretic effects. Effect, antithrombotic effect. Specifically, there are plant extracts containing steroid saponins such as steroid saponins and barley winter extract in addition to prednisolone, beclomethasone, betamethasone, fluticasone, dexamethasone, hydrocortisone and the like as steroidal anti-inflammatory agents. In addition, as non-steroidal anti-inflammatory agents, allantoin, guaiazulene, indomethacin, ketoprofen, piroxicam, acetaminophen, aspirin, salicylic acid, bufemaxac, suprofen, ibuprofen piconol, flurbiprofen, pranoprofen, diclofenac sodium, sodium salicylate, Plant extracts and propolis extracts containing triterpenoid saponins such as triterpenoid saponins and licorice extracts such as glycyrrhizic acid, glycyrrhetinic acid and their salts and esterified in addition to methyl salicylate, benzadac, felbinac, ufernamate, diphenhydramine hydrochloride, etc. is there. Among these, non-steroidal anti-inflammatory agents are preferable in consideration of safety due to continuous use, and glycyrrhizic acid and its salt, glycyrrhetinic acid and its salt are considered in consideration of skin softness improving effect and improvement in feeling of use. Or esterified products, allantoin, and guaiazulene are more preferable, and glycyrrhizinate is more preferable.

(c)成分の配合量は、組成物全量中に0.001〜2質量%、好ましくは0.01〜1.5質量%、さらに好ましくは0.05〜1質量%である。(c)成分は1種単独で用いてもよいし、2種類以上を併用してもよい。   (C) The compounding quantity of a component is 0.001-2 mass% in a composition whole quantity, Preferably it is 0.01-1.5 mass%, More preferably, it is 0.05-1 mass%. (C) A component may be used individually by 1 type and may use 2 or more types together.

さらに、本発明の皮膚化粧料には、化粧料に常用されている成分を本発明の性能を損なわない範囲で配合してもよい。   Furthermore, you may mix | blend the component normally used for cosmetics with the skin cosmetics of this invention in the range which does not impair the performance of this invention.

次に、実施例を挙げて本発明をさらに詳細に説明する。
<アルギニン誘導体の合成例>
<化合物1>
L−アルギニン174g(1モル)をイオン交換水406gに溶解してオートクレーブに仕込み、オートクレーブ内の空気を乾燥窒素で置換した。次に60℃に昇温し、プロピレンオキシド64g(1.1モル)を1時間かけて滴下した後、60℃に保ちさらに6時間反応した。反応終了後、30分間乾燥窒素でバブリングして未反応のプロピレンオキシドを除去し、オートクレーブから反応液を取り出し、溶媒を減圧留去して反応生成物を得た。反応生成物のH−NMRスペクトルを測定し、下記算出法に基づいて、反応生成物のプロピレンオキシド平均付加モル数を算出した。その結果、化合物1のプロピレンオキシド平均付加モル数は1.02モルであった。この反応生成物に対してイオン交換水を加え、アルギニン誘導体の25質量%水溶液を調製し、以下の検討に用いた。
Next, the present invention will be described in more detail with reference to examples.
<Synthesis example of arginine derivative>
<Compound 1>
174 g (1 mol) of L-arginine was dissolved in 406 g of ion exchange water and charged into the autoclave, and the air in the autoclave was replaced with dry nitrogen. Next, the temperature was raised to 60 ° C., and 64 g (1.1 mol) of propylene oxide was added dropwise over 1 hour, and the reaction was further continued for 6 hours while maintaining the temperature at 60 ° C. After completion of the reaction, unreacted propylene oxide was removed by bubbling with dry nitrogen for 30 minutes, the reaction solution was taken out from the autoclave, and the solvent was distilled off under reduced pressure to obtain a reaction product. The 1 H-NMR spectrum of the reaction product was measured, and the propylene oxide average addition mole number of the reaction product was calculated based on the following calculation method. As a result, the average number of moles of propylene oxide added in Compound 1 was 1.02 moles. Ion exchange water was added to the reaction product to prepare a 25% by mass aqueous solution of an arginine derivative, which was used for the following studies.

H−NMR測定条件>
使用機種:日本電子株式会社製 ECA−600(600MHz)
測定溶媒:D
内部標準:DSS(2,2−ジメチル−2−シラペンタン−5−スルホン酸ナトリウム)
<ヒドロキシプロピル基の平均付加モル数の算出方法>
S1:δ=1.5〜1.7ppmのアルギニンのβ−炭素、γ−炭素に結合している水素に帰属されるピークの積算強度、
S2:δ=2.5〜2.8ppmのα−アミノ基に付加したヒドロキシプロピル基の1位の炭素に結合している水素に帰属されるピークの積算強度とし、
ヒドロキシプロピル基の平均付加モル数=(S2/S1)×2で算出した。
<1 H-NMR measurement conditions>
Model used: ECA-600 (600 MHz) manufactured by JEOL Ltd.
Measuring solvent: D 2 O
Internal standard: DSS (2,2-dimethyl-2-silapentane-5-sulfonic acid sodium salt)
<Calculation method of average added mole number of hydroxypropyl group>
S1: cumulative intensity of peaks attributed to hydrogen bonded to β-carbon and γ-carbon of arginine at δ = 1.5 to 1.7 ppm,
S2: δ = 2.5 to 2.8 ppm as the integrated intensity of the peak attributed to hydrogen bonded to the 1-position carbon of the hydroxypropyl group added to the α-amino group,
The average number of moles of hydroxypropyl group added was calculated by (S2 / S1) × 2.

<化合物2>
L−アルギニン174g(1モル)とプロピレンオキシド116g(2モル)を用いた以外は、化合物1と同様の条件で反応を行った。得られた反応生成物のH−NMRスペクトルより求めた化合物2のプロピレンオキシド平均付加モル数は1.84モルであった。この反応生成物に対してイオン交換水を加え、アルギニン誘導体25質量%水溶液を調製し、以下の検討に用いた。
(評価方法)
表1(化粧水)、表3(水中油型乳液)に示す皮膚化粧料を調製し、(1)肌へのなじみ性、(2)べたつき感、(3)保湿効果の持続性、(4)肌の柔軟性改善効果、(5)肌荒れ改善効果、(6)肌保護効果 について、下記の方法によって評価を行った。
<Compound 2>
The reaction was conducted under the same conditions as for Compound 1 except that 174 g (1 mol) of L-arginine and 116 g (2 mol) of propylene oxide were used. The average addition mole number of propylene oxide of Compound 2 obtained from the 1 H-NMR spectrum of the obtained reaction product was 1.84 mol. Ion exchange water was added to this reaction product to prepare a 25% by mass aqueous solution of an arginine derivative, which was used for the following studies.
(Evaluation method)
The skin cosmetics shown in Table 1 (skin lotion) and Table 3 (oil-in-water emulsion) were prepared. (1) Skin conformability, (2) Stickiness, (3) Sustained moisturizing effect, (4 The following methods were used to evaluate the effects of improving skin flexibility, (5) improving skin roughness, and (6) protecting skin.

(1)肌へのなじみ性
20名の女性(22〜40歳)をパネラーとし、調製した皮膚化粧料を洗顔後に塗布した。そして使用時の肌へのなじみ性について、下記のように判定した。
2点:肌へのなじみが良いと感じた場合。
1点:肌へのなじみがやや悪いと感じた場合。
0点:肌へのなじみが悪いと感じた場合。
20名の合計点を求め、以下のように評価した。
○:合計点が30点以上(かつ0点評価なし):肌へのなじみ性に優れた皮膚化粧料である。
×:合計点が30点未満:肌へのなじみ性が良くない皮膚化粧料である。
(1) Familiarity with skin 20 females (22 to 40 years old) were panelists, and the prepared skin cosmetic was applied after washing their face. And the conformability to the skin at the time of use was determined as follows.
2 points: When familiar with skin.
1 point: When familiar with skin, feels slightly worse.
0 point: When it is felt that the familiarity with the skin is bad.
The total score of 20 people was calculated and evaluated as follows.
A: The total score is 30 points or more (and there is no 0 point evaluation): a skin cosmetic that is excellent in conformity to the skin.
X: The total score is less than 30: skin cosmetics that are not well-familiar with the skin.

(2)べたつき感
20名の女性(22〜40歳)をパネラーとし、調製した皮膚化粧料を洗顔後に塗布した。そして塗布時および塗布10分後の肌のべたつき感について、下記のように判定した。
2点:塗布時、塗布10分後ともにべたつき感を感じなかった場合。
1点:塗布時または塗布10分後のどちらかにべたつき感を感じた場合。
0点:塗布時、塗布10分後ともにべたつき感を感じた場合。
20名の合計点を求め、以下のように評価した。
○:合計点が30点以上(かつ0点評価なし):べたつき感を感じない皮膚化粧料である。
×:合計点が30点未満:べたつき感のある皮膚化粧料である。
(2) Stickiness 20 women (22 to 40 years old) were panelists, and the prepared skin cosmetic was applied after washing their face. And the stickiness of the skin at the time of application | coating and 10 minutes after application | coating was determined as follows.
2 points: At the time of application, when no stickiness was felt 10 minutes after application.
1 point: When a sticky feeling is felt either during application or 10 minutes after application.
0 point: When a sticky feeling was felt at the time of application and 10 minutes after application.
The total score of 20 people was calculated and evaluated as follows.
◯: Total score of 30 points or more (and no score of 0): Skin cosmetics that do not feel sticky.
X: The total score is less than 30: It is a skin cosmetic with a sticky feeling.

(3)保湿効果の持続性
20名の女性(22〜40歳)をパネラーとし、調製した皮膚化粧料を洗顔後に塗布した。そして2時間後の肌の潤いついて、下記のように判定した。
2点:使用直後と変わらず肌が十分潤っていると感じた場合。
1点:使用直後と比べてやや肌の潤いが足りないと感じた場合。
0点:使用直後と比べて明らかに肌の潤いが足りないと感じた場合。
20名の合計点を求め、以下のように評価した。
○:合計点が30点以上(かつ0点評価なし):保湿効果の持続性が良好な皮膚化粧料である。
×:合計点が30点未満:保湿効果の持続性がない皮膚化粧料である。
(3) Sustainability of moisturizing effect 20 females (22 to 40 years old) were panelists, and the prepared skin cosmetic was applied after washing their face. Then, after 2 hours, the skin was moistened and judged as follows.
2 points: When the skin feels sufficiently moistened just after use.
1 point: When the skin feels slightly moisturized compared to immediately after use.
0 points: When the skin feels that the skin is not sufficiently moistened immediately after use.
The total score of 20 people was calculated and evaluated as follows.
A: The total score is 30 points or more (and there is no evaluation of 0 points): a skin cosmetic with a good moisturizing effect.
X: The total score is less than 30 points: skin cosmetics having no moisturizing effect.

(4)肌の柔軟性改善効果
20名の女性(22〜40歳)をパネラーとし、調製した皮膚化粧料を1日2回、2週間使用してた。そして2週間後の肌の状態について、下記のように判定した。
2点:明らかに肌がふっくらと柔らかくなったと感じた場合。
1点:やや肌がふっくらと柔らかくなったと感じた場合。
0点:肌の柔軟性改善効果がまったくないと感じた場合。
20名の合計点を求め、以下のように評価した。
○:合計点が30点以上(かつ0点評価なし):肌の柔軟性改善効果に優れた皮膚化粧料である。
×:合計点が30点未満:肌の柔軟性改善効果がない皮膚化粧料である。
(4) Skin flexibility improvement effect 20 women (22 to 40 years old) were used as panelists, and the prepared skin cosmetics were used twice a day for 2 weeks. The skin condition after 2 weeks was determined as follows.
2 points: When the skin clearly feels soft and soft.
1 point: When the skin feels soft and soft.
0 point: When it feels that there is no skin softness improvement effect at all.
The total score of 20 people was calculated and evaluated as follows.
A: The total score is 30 points or more (and there is no 0 point evaluation): a skin cosmetic excellent in the effect of improving skin flexibility.
X: The total score is less than 30: skin cosmetics that do not have an effect of improving skin flexibility.

(5)肌荒れ改善効果
肌荒れを感じている10名の女性(28〜40歳)をパネラーとし、調製した皮膚化粧料を1日2回、2週間使用した。そして2週間後の肌の状態について、下記のように判定した。
2点:肌荒れが明らかに治ってきたと感じた場合。
1点:肌荒れがやや治ってきたと感じた場合。
0点:肌荒れ改善効果が全くないと感じた場合。
10名の合計点を求め、以下のように評価した。
○:合計点が15点以上(かつ0点評価なし):肌荒れ改善効果に優れた皮膚化粧料である。
×:合計点が15点未満:肌荒れ改善効果がない皮膚化粧料である。
(5) Rough skin improvement effect 10 women (28 to 40 years old) who feel rough skin were used as panelists, and the prepared skin cosmetics were used twice a day for 2 weeks. The skin condition after 2 weeks was determined as follows.
2 points: When it is felt that rough skin has been cured.
1 point: When it feels that the rough skin has been cured somewhat.
0 point: When it feels that there is no skin roughening effect at all.
The total score of 10 people was calculated and evaluated as follows.
A: The total score is 15 points or more (and there is no evaluation of 0 points): a skin cosmetic excellent in rough skin improvement effect.
X: The total score is less than 15: It is a skin cosmetic that does not have a rough skin improvement effect.

(6)肌保護効果
20名の女性(22〜40歳)をパネラーとし、調製した皮膚化粧料を1日2回、2週間使用した。そして2週間後の肌のバリア性について Vapo meter を用いて評価した。バリア能改善率が20%以上の場合、肌保護効果に優れた化粧水であると評価した。
○:バリア能改善率が20%以上:肌保護効果に優れた皮膚化粧料である。
×:バリア能改善率が20%未満:肌保護効果がない皮膚化粧料である。
(6) Skin protection effect 20 females (22 to 40 years old) were used as panelists, and the prepared skin cosmetics were used twice a day for 2 weeks. Then, the skin barrier properties after 2 weeks were evaluated using Vapo meter. When the barrier ability improvement rate was 20% or more, it was evaluated as a skin lotion having an excellent skin protection effect.
○: Barrier ability improvement rate of 20% or more: A skin cosmetic excellent in skin protecting effect.
X: Barrier ability improvement rate is less than 20%: It is a skin cosmetic having no skin protecting effect.

結果を表1、表3に示す。 The results are shown in Tables 1 and 3.

本発明の皮膚化粧料(化粧水)は、実施例1〜3より、肌へ素早くなじむとともに、べたつき感を感じることがなく、保湿効果の持続性、肌の柔軟性改善効果、肌荒れ改善効果および肌保護効果に優れていた。
一方、比較例1〜3では、十分な性能が得られなかった。比較例1では、(a)成分が含有されていないため、肌へのなじみが悪く、べたつきを感じ、肌の柔軟性改善効果も十分ではなかった。比較例2では、(a)成分の代わりにL-アルギニンが含まれているため、肌へのなじみが悪く、べたつきがあった。比較例3では、(b)成分が含有されていないため、肌へのなじみが悪く、保湿効果の持続性、肌の柔軟性改善効果、肌荒れ改善効果および肌保護効果も十分ではなかった。
また、本発明の皮膚化粧料(水中油型乳液)は、実施例4〜6より、肌へ素早くなじむとともに、べたつき感を感じることがなく、保湿効果の持続性、肌の柔軟性改善効果、肌荒れ改善効果および肌保護効果に優れていた。
一方、比較例4では、十分な性能が得られなかった。比較例4では、肌へのなじみが悪く、べたつきを感じた。
The skin cosmetic (skin lotion) of the present invention quickly adapts to the skin from Examples 1 to 3, and does not feel a sticky feeling. It maintains the moisturizing effect, improves the skin flexibility, improves the rough skin, and Excellent skin protection effect.
On the other hand, in Comparative Examples 1-3, sufficient performance was not obtained. In Comparative Example 1, since the component (a) was not contained, the familiarity with the skin was poor, the skin was sticky, and the effect of improving the skin flexibility was not sufficient. In Comparative Example 2, since L-arginine was contained instead of the component (a), the familiarity with the skin was bad and sticky. In Comparative Example 3, since the component (b) was not contained, the familiarity with the skin was poor, and the durability of the moisturizing effect, the skin flexibility improving effect, the skin roughness improving effect and the skin protecting effect were not sufficient.
In addition, the skin cosmetics (oil-in-water emulsion) of the present invention, from Examples 4 to 6, quickly adapt to the skin and do not feel sticky, maintain the moisturizing effect, improve skin flexibility, Excellent skin roughening effect and skin protection effect.
On the other hand, in Comparative Example 4, sufficient performance was not obtained. In Comparative Example 4, the familiarity with the skin was bad, and stickiness was felt.

本発明の皮膚化粧料は、肌へ素早くなじむとともに、べたつき感を感じることがなく、保湿効果の持続性、肌の柔軟性改善効果、肌荒れ改善効果および肌保護効果に優れた皮膚用の化粧料として使用し得る。   The skin cosmetic of the present invention quickly adapts to the skin, does not feel sticky, and has excellent moisturizing effect, skin flexibility improvement effect, skin roughness improvement effect and skin protection effect. Can be used as

Claims (2)

(a)式(I)で示されるアルギニン誘導体0.05〜10質量%、(b)水溶性高分子化合物0.01〜3質量%含有する皮膚化粧料。

(R、Rは水素原子又はヒドロキシプロピル基であり、R、Rの少なくともどちらかはヒドロキシプロピル基を示す。Rは水素原子又はアルカリ金属原子を示す。)
(A) A skin cosmetic containing 0.05 to 10% by mass of an arginine derivative represented by the formula (I) and (b) 0.01 to 3% by mass of a water-soluble polymer compound.

(R 1 and R 2 are a hydrogen atom or a hydroxypropyl group, and at least one of R 1 and R 2 represents a hydroxypropyl group. R 3 represents a hydrogen atom or an alkali metal atom.)
さらに、(c)抗炎症剤0.001〜2質量%含有する請求項1に記載の皮膚化粧料。
The skin cosmetic according to claim 1, further comprising (c) 0.001 to 2% by mass of an anti-inflammatory agent.
JP2010147875A 2010-06-29 2010-06-29 Skin cosmetics Active JP5577889B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2010147875A JP5577889B2 (en) 2010-06-29 2010-06-29 Skin cosmetics

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2010147875A JP5577889B2 (en) 2010-06-29 2010-06-29 Skin cosmetics

Publications (2)

Publication Number Publication Date
JP2012012311A JP2012012311A (en) 2012-01-19
JP5577889B2 true JP5577889B2 (en) 2014-08-27

Family

ID=45599179

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010147875A Active JP5577889B2 (en) 2010-06-29 2010-06-29 Skin cosmetics

Country Status (1)

Country Link
JP (1) JP5577889B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112957270B (en) * 2021-03-15 2022-10-14 茵素科技(广州)有限公司 Poly-hydroxypropyl arginine and derivative thereof-polyhydroxy sugar complex, and preparation method and application thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4523109B2 (en) * 2000-03-13 2010-08-11 日油株式会社 Skin cosmetics
JP2001354514A (en) * 2000-06-13 2001-12-25 Lion Corp Composition for external use
JP2002087928A (en) * 2000-09-18 2002-03-27 Kyowa Hakko Kogyo Co Ltd Humectant for makeup and cosmetic
JP4193443B2 (en) * 2001-08-21 2008-12-10 味の素株式会社 Disinfectant and preservative
JP3938060B2 (en) * 2002-02-05 2007-06-27 味の素株式会社 Cosmetic composition
JP2004083453A (en) * 2002-08-26 2004-03-18 Seiwa Kasei:Kk New n-glyceryl derivative of amino acid, and skin preparation for external use and hair cosmetic containing the same
JP2004131423A (en) * 2002-10-10 2004-04-30 Lion Corp Cosmetic
AU2003289171A1 (en) * 2002-12-06 2004-06-30 Seiwa Kasei Company, Limited Cosmetic preparation containing glycerylamino acid derivative
JP5625914B2 (en) * 2008-12-26 2014-11-19 日油株式会社 Arginine derivative and cosmetic containing the same
JP5494142B2 (en) * 2010-03-31 2014-05-14 日油株式会社 Topical skin preparation
JP5494141B2 (en) * 2010-03-31 2014-05-14 日油株式会社 Topical skin preparation

Also Published As

Publication number Publication date
JP2012012311A (en) 2012-01-19

Similar Documents

Publication Publication Date Title
JP4670366B2 (en) Skin cosmetics
TW200934480A (en) Novel salts and their uses
JP2016135787A (en) Composition for external use
WO2016101264A1 (en) Cosmetic compositions comprising p-anisic acid and hydroxyacetophenone, their uses and cosmetic methods thereof
JP5577889B2 (en) Skin cosmetics
CN107530050A (en) Ultrasonic diagnosis application type contact medium
KR20090067019A (en) Peeling cosmetic material and method for using the same
WO2016159186A1 (en) Gel-like composition for external application
JP2013234173A (en) Semi solid medicine for oral cavity
JP2001097848A (en) Preparation composition for external use
CN108136224B (en) Oral care compositions
CN107875078A (en) A kind of anti-inflammatory oral cavity nursing agent
JP6925929B2 (en) Oral composition
JP5097363B2 (en) Antifungal composition
WO2020258205A1 (en) Cosmetic composition for making up and/or caring for keratin materials
JP2005104916A (en) Antifungal composition
JP2013095737A (en) Skin cosmetic
JP2005104917A (en) Antifungal composition
CN108030727A (en) A kind of anti-inflammatory hemostatic toothpaste
CN107898709A (en) A kind of oral cavity nursing agent of anti-inflammatory
CN107951780A (en) A kind of toothpaste containing peppermint oil
JP2022117408A (en) Composition for external application
JP2021169415A (en) Composition for intraoral application
CN107982147A (en) One kind hemostasis oral cavity care cream liquid
CN107951779A (en) A kind of oral care lotion containing peppermint oil

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20130611

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20140228

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20140610

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20140623

R150 Certificate of patent or registration of utility model

Ref document number: 5577889

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250